Bioequivalence and Bioavailability Forum

A posteriori power - No.666 [Power / Sample Size]

posted by Helmut  – Vienna, Austria, 2011-03-08 16:03 (5593 d 22:38 ago) – Posting: # 6726
Views: 8,423

Dear Marcel,

actually you have proven the CV from the pilot in your pivotal study.
This renders the argument of the agency as straight !

It’s common for bisphonates that published (=old) studies show higher variability than more recent ones due to improvements in bioanalytics.

—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! 
Helmut Schütz


The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

• Consumer risk Marcel 2011-03-08 10:56 [Power / Sample Size] 
  • Consumer risk ElMaestro 2011-03-08 11:30
    • Consumer risk Marcel 2011-03-08 12:01
      • Consumer risk ElMaestro 2011-03-08 12:13
      • A posteriori power - No.666 Helmut 2011-03-08 12:27
        • A posteriori power - No.666 Marcel 2011-03-08 12:50
          • A posteriori power - No.666 ElMaestro 2011-03-08 13:06
          • A posteriori power - No.666 Helmut 2011-03-08 13:41
            • A posteriori power - No.666 Marcel 2011-03-08 14:13
              • A posteriori power - No.666 Helmut 2011-03-08 14:27
                • A posteriori power - No.666 Marcel 2011-03-08 14:49
                  • A posteriori power - No.666Helmut 2011-03-08 15:03
                    • A posteriori power - No.666 Marcel 2011-03-08 15:28
              • ... ElMaestro 2011-03-09 23:16